Amundi’s Astrana Health ASTH Stock Holding History

Amundi’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-389	Closed	-$15K	–	1993
2022 Q3	$15K	Hold	389	–	–	﹤0.01%	1772
2022 Q2	$17K	Hold	389	–	–	﹤0.01%	1613
2022 Q1	$18K	Hold	389	–	–	﹤0.01%	1607
2021 Q4	$24K	Hold	389	–	–	﹤0.01%	1635
2021 Q3	$35K	Buy	+389	New	+$33.1K	﹤0.01%	1542

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWS

Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Amundi's ASTH Position: Q4 2022 in Review

Amundi sold out of Astrana Health (ASTH) in Q4 2022, closing a stake of 389 shares — an estimated $15K sold.

Amundi first reported a position in ASTH in Q3 2021 and held it in 5 quarters. The position peaked at $35K in Q3 2021. 130 funds tracked by Wall St. Rank hold ASTH as of Q4 2022.

Amundi reported no remaining Astrana Health position as of Q4 2022 after selling out during the quarter.
Amundi sold 389 Astrana Health shares in Q4 2022, an estimated $15K.
Amundi first reported a position in Astrana Health in Q3 2021 and held it in 5 quarters.
Amundi's Astrana Health position peaked at $35K in Q3 2021.
130 funds tracked by Wall St. Rank held Astrana Health as of Q4 2022.

Based on Amundi's 13F filing for Q4 2022, filed 14 Feb 2023.